Two-Pronged attack aims to shrink inoperable pancreatic tumors
NCT ID NCT07208539
Summary
This study is testing a two-step treatment for pancreatic cancer that is borderline or locally advanced, meaning it is difficult or impossible to remove with surgery right away. The goal is to see if giving two different combinations of chemotherapy drugs plus an immunotherapy drug can shrink the tumors enough so that surgery becomes an option. Researchers will measure if this approach helps patients live longer and how safe the treatment is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.